Search research articles
Contact Us
Filters
Showing results (141-150 of 244) with videos related to
Page
of 25
Sort By:
Cancer
|
August 30, 2008
Interferon-alpha for recurrent World Health Organization grade 1 intracranial meningiomas
Marc C Chamberlain, Michael J Glantz
Expert Review of Neurotherapeutics
|
April 28, 2005
Intracranial meningiomas: diagnosis and treatment
Marc C Chamberlain, Deborah T Blumenthal
Journal of Neuro-Oncology
|
August 4, 2010
Recurrent spinal cord glioblastoma: salvage therapy with bevacizumab
Marc C Chamberlain, Sandra K Johnston
Neuro-Oncology
|
March 23, 2012
Surgery, a prognostic marker for progression-free survival?
Marc C Chamberlain, Daniel L Silbergeld
Journal of Neuro-Oncology
|
July 14, 2009
Salvage therapy with single agent bevacizumab for recurrent glioblastoma
Marc C Chamberlain, Sandra K Johnston
Current Oncology Reports
|
December 21, 2002
Systemic chemotherapy, intrathecal chemotherapy, and symptom management in the treatment of leptomeningeal metastasis
Stacey L Berg, Marc C Chamberlain
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 2, 2007
Intra-CSF rituximab for lymhomatous meningitis
Marc C Chamberlain, Michael J Glantz
CNS Oncology
|
July 24, 2014
State of the art and perspectives in the treatment of glioblastoma
Sean A Grimm, Marc C Chamberlain
CNS Oncology
|
May 28, 2016
Anaplastic astrocytoma
Sean A Grimm, Marc C Chamberlain
Nature Clinical Practice. Oncology
|
June 11, 2008
Mechanisms of disease: temozolomide and glioblastoma--look to the future
Maciej M Mrugala, Marc C Chamberlain
Page
of 25
Search research articles
Search
Showing results (141-150 of 244) with videos related to
Sort By:
Page
of 25
Cancer
|
August 30, 2008
Interferon-alpha for recurrent World Health Organization grade 1 intracranial meningiomas
Marc C Chamberlain, Michael J Glantz
Expert Review of Neurotherapeutics
|
April 28, 2005
Intracranial meningiomas: diagnosis and treatment
Marc C Chamberlain, Deborah T Blumenthal
Journal of Neuro-Oncology
|
August 4, 2010
Recurrent spinal cord glioblastoma: salvage therapy with bevacizumab
Marc C Chamberlain, Sandra K Johnston
Neuro-Oncology
|
March 23, 2012
Surgery, a prognostic marker for progression-free survival?
Marc C Chamberlain, Daniel L Silbergeld
Journal of Neuro-Oncology
|
July 14, 2009
Salvage therapy with single agent bevacizumab for recurrent glioblastoma
Marc C Chamberlain, Sandra K Johnston
Current Oncology Reports
|
December 21, 2002
Systemic chemotherapy, intrathecal chemotherapy, and symptom management in the treatment of leptomeningeal metastasis
Stacey L Berg, Marc C Chamberlain
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 2, 2007
Intra-CSF rituximab for lymhomatous meningitis
Marc C Chamberlain, Michael J Glantz
CNS Oncology
|
July 24, 2014
State of the art and perspectives in the treatment of glioblastoma
Sean A Grimm, Marc C Chamberlain
CNS Oncology
|
May 28, 2016
Anaplastic astrocytoma
Sean A Grimm, Marc C Chamberlain
Nature Clinical Practice. Oncology
|
June 11, 2008
Mechanisms of disease: temozolomide and glioblastoma--look to the future
Maciej M Mrugala, Marc C Chamberlain
Page
of 25